Alternative Treatments of Vitamin D Deficiency
Comparison of UVB and Vitamin D Supplementation in Treatment of Vitamin D Deficiency
1 other identifier
interventional
32
1 country
1
Brief Summary
The purpose of the study is to compare the efficiency of UVB and vitamin D supplementation in treatment of vitamin D deficiency.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2010
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2011
CompletedFirst Submitted
Initial submission to the registry
December 22, 2011
CompletedFirst Posted
Study publicly available on registry
January 19, 2012
CompletedJanuary 19, 2012
January 1, 2012
1.2 years
December 22, 2011
January 15, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Vitamin D (nmol/l).
Vitamin D was measured in a bloodsample to determine baseline status.
Week 0
Vitamin D (nmol/l)
Vitamin D was measured in a bloodsample to follow the change from baseline in vitamin D level at week 3.
Week 3
Vitamin D
Vitamin D was measured in a bloodsample to follow the change from baseline in vitamin D level at week 6.
Week 6
Secondary Outcomes (4)
Parathyroid hormone (pmol/l).
Week 0, 3 and 6.
Albumin (g/l).
Week 0, 3 and 6.
Calcium (mmol/l)
Week 0, 3 and 6.
Hemoglobin A 1c (percentage HbA1c of total hemoglobin).
Week 0, 3 and 6.
Study Arms (2)
UVB
ACTIVE COMPARATORUVB exposed group
Oral vitamin D tablet
ACTIVE COMPARATORVitamin D supplementation
Interventions
1 daily tablet of 1600 IU vitamin D3 and 1000 mg calcium
Eligibility Criteria
You may qualify if:
- Vitamin D deficiency (\< 25 nmol/l)
- Age 15 or above
You may not qualify if:
- Travel south of 45 degrees latitude during the trial.
- Ongoing treatment with vitamin D supplementation.
- Intake of light sensitive medicine, such as tetracyclins.
- Skin light eruptions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Lund Universitylead
Study Sites (1)
Department of Dermatology, Lund University Malmoe
Malmo, 205 02, Sweden
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Åke Svensson, Assoc. Prof., MD, PhD
Department of Dermatology, Lund University, Malmoe
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
December 22, 2011
First Posted
January 19, 2012
Study Start
February 1, 2010
Primary Completion
April 1, 2011
Study Completion
November 1, 2011
Last Updated
January 19, 2012
Record last verified: 2012-01